Retinal Image analysis for the Screening of Diabetic Retinopathy
Not Applicable
- Conditions
- Health Condition 1: H350- Background retinopathy and retinalvascular changes
- Registration Number
- CTRI/2019/08/020867
- Lead Sponsor
- Department of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the people aged 25 and above will be involved in the retinal image screening and above 35 year people will be examined for the presence of diabetes.Apart from this, height, weight,waist will also be taken from all participating people.
Exclusion Criteria
People below 25 year and one who are having cataract will be excluded from the screening.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To create a database of fundus images from different age groups of different areas. Here, we will capture the fundus images of people of age group 20-65. Apart from this, we will measure glucose level, weight, height, waist of the participant for further diagnosis of Diabetic Retinopathy.Timepoint: 3 weeks
- Secondary Outcome Measures
Name Time Method once the primary goals are achieved, we will follow up the participant after the regular intervals to confirm any vascular changes in the eye. This follow up gives the rate of visual morbidity along with the role glucose level in worsening the condition of Diabetic RetinopathyTimepoint: 12 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of retinal vascular changes in diabetic retinopathy as studied in CTRI/2019/08/020867?
How does retinal image analysis compare to standard-of-care screening methods for non-proliferative diabetic retinopathy?
What biomarkers are used to identify patients at high risk for NVD/NVE progression in CTRI/2019/08/020867?
What adverse events are associated with retinal imaging technologies in rural diabetic populations?
Are there combination approaches or competitor drugs for early detection of NVD/NVE in diabetic retinopathy?